Menu

European Commission Recommends €100 Billion for Research

The budget is smaller than what some researchers hoped for, and too high for at least one EU member state.

May 3, 2018
Jim Daley

ISTOCK, ARTJAZZ

On Wednesday (May 2), the European Commission recommended a spending plan that includes €100 billion (about $120 billion USD) for research between 2021 and 2027. According to a fact sheet released by the Commission, the proposed budget accounts for the impact of Brexit—the 2016 referendum that will result in the United Kingdom exiting the European Union (EU)—on the European economy. The proposal will be a 50 percent increase in spending compared with the previous period but is still short of what some researchers hoped for.

In a February interview with Science, Robert-Jan Smits, the Commission’s former director-general for research, says he anticipated a budget that included “at least €120 billion” for research. He’s not alone in that opinion.

“100 billion euro is a bare minimum for an . . . impactful [program] that will need to meet many challenges,” Kurt Deketelaere, the secretary-general of the League of European Research Universities (LERU), tells Science. In a press release, the LERU says, “the proposed increased investment in research, innovation and education by the Commission is acceptable.”

In a statement, European Commission President Jean-Claude Juncker says the proposed budget is “an opportunity to shape our future as a new, ambitious Union of 27 bound together by solidarity. With [the] proposal we have put forward a pragmatic plan for how to do more with less.”

The budget proposal is the first move in what a May 2 Science article says will be extensive negotiations between the European Parliament and the European Union’s member states. Times Higher Education reports that the Netherlands has already rejected the budget, contending that it’s still too large for the post-Brexit EU’s economy.

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Libraries of pooled lentiviral constructs that express two different sgRNA to all 19,000 human protein-coding genes improve overall gene activation or repression and generate more robust screening results
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
In this webinar, learn about antibody-drug conjugates (ADCs) and their function, how to analyze and characterize ADCs, and developing ADC processes and formulations.
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3.